Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P39060 (
endostatin
)
2,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The aims of this study were 1) to characterize changes in matrix metalloproteinase (MMP),
endostatin
, and vascular endothelial growth factor (VEGF)-A expression in skeletal muscle in response to a single bout of exercise in humans; and 2) to determine if any exchange of
endostatin
and VEGF-A between circulation and the exercising leg is associated with a change in the tissue expression or plasma concentration of these factors. Ten healthy males performed 65 min of cycle exercise, and muscle biopsies were obtained from the vastus lateralis muscle at rest and immediately and 120 min after exercise. In the muscle biopsies, measurements of mRNA expression levels of MMP-2, MMP-9,
MMP-14
, and tissue inhibitor of metalloproteinase; VEGF and
endostatin
protein levels; and MMP activities were performed. Femoral arterial and venous concentrations of VEGF-A and
endostatin
were determined before, during, and 120 min after exercise. A single bout of exercise increased MMP-9 mRNA and activated MMP-9 protein in skeletal muscle. No measurable increase of
endostatin
was observed in the skeletal muscle or in plasma following exercise. A concurrent increase in skeletal muscle VEGF-A mRNA and protein levels was induced by exercise, with no signs of peripheral uptake from the circulation. However, a decrease in plasma VEGF-A concentration occurred following exercise. Thus 1) a single bout of exercise activated the MMP system without any resulting change in tissue
endostatin
protein levels, and 2) the increased VEGF-A protein levels are due to changes in the skeletal muscle tissue itself. Other mechanisms are responsible for the observed exercise-induced decrease in VEGF-A in plasma.
...
PMID:A single bout of exercise activates matrix metalloproteinase in human skeletal muscle. 1725 65
Synthesis and activation of matrix metalloproteinases during wound healing are important for remodeling the extracellular matrix and modulating various cellular functions. The membrane-type 1 matrix metalloproteinase (
MMP-14
) has been shown to play a key role during these processes. To analyze the function of epidermal-derived
MMP-14
during skin repair we generated mice lacking
MMP-14
expression in the epidermis (
MMP-14
(ep-/-)). These mice displayed overall normal skin morphology and epidermal differentiation patterns. Wound repair in
MMP-14
(ep-/-) followed the same kinetics as in wild type mice (
MMP-14
(ep+/+)), and infiltration of neutrophils, leukocytes, and macrophages into the wound site was comparable. Microscopic analysis showed no altered re-epithelialization in the absence of epidermal
MMP-14
. Furthermore, epidermal differentiation at the end of the repair process and scar formation was normal. However, at day 14 post wounding, sustained angiogenesis was observed in
MMP-14
(ep-/-) mice in contrast to control mice. Interestingly, decreased levels of
endostatin
were detected in wound lysates of
MMP-14
(ep-/-) mice as well as in cultured keratinocytes. Taken together, these data indicate that
MMP-14
expression in keratinocytes is dispensable for skin homeostasis and repair, but plays a crucial role in the epidermal-dermal crosstalk leading to modulation of vessel density.
...
PMID:Loss of epidermal MMP-14 expression interferes with angiogenesis but not with re-epithelialization. 2271 26